Bioceltix S.A. (WSE:BCX)
Poland · Delayed Price · Currency is PLN 74.80
0.00 (0.00%)
Sep 25, 2026, 10:23 AM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 413.81 million as of September 24, 2026. Its market cap has decreased by -21.61% in one year.
Market Cap
413.81M
Enterprise Value
353.25M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
74.80
ChartMarket Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 413.81M, an increase of 259.72%. That is a compound annual growth rate of 29.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 413.81M | 8.29% |
| Dec 30, 2025 | 382.14M | -11.42% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
| Nov 8, 2021 | 115.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 627.97M |
| Captor Therapeutics Spolka Akcyjna | 451.73M |
| Ryvu Therapeutics | 369.92M |
| BIOTON | 310.40M |
| Synthaverse | 219.36M |
| Molecure | 159.67M |
| Mabion | 126.07M |
| Poltreg | 120.10M |